Last updated on May 2020

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata


Brief description of study

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the treatment of severe or very severe alopecia areata.

Clinical Study Identifier: NCT03570749

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.